Sign up to save your podcasts
Or
Share Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
View all episodes
By American College of Physicians
4.5
183183 ratings
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
More shows like Annals On Call Podcast
View all
JAMA Editors' Summary
141 Listeners
NEJM This Week
321 Listeners
AFP: American Family Physician Podcast
699 Listeners
JAMA Clinical Reviews
501 Listeners
Mayo Clinic Talks
290 Listeners
Frankly Speaking About Family Medicine
261 Listeners
The Curbsiders Internal Medicine Podcast
3,367 Listeners
Core IM | Internal Medicine Podcast
1,152 Listeners
The Internet Book of Critical Care Podcast
704 Listeners
JAMA Medical News
92 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
362 Listeners
Run the List
255 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners
The Curious Clinicians
373 Listeners